ID

34332

Description

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01392131

Lien

https://clinicaltrials.gov/show/NCT01392131

Mots-clés

  1. 16/01/2019 16/01/2019 -
  2. 14/05/2019 14/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatocellular Carcinoma NCT01392131

Eligibility Hepatocellular Carcinoma NCT01392131

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
Description

ID.1

Type de données

boolean

patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
Description

ID.2

Type de données

boolean

patients with hcc who have evidence of tumor metastasis
Description

ID.3

Type de données

boolean

patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
Description

ID.4

Type de données

boolean

patients with hcc in whom all possible treatment options have been exhausted.
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
Description

ID.6

Type de données

boolean

patients with hcc who have no evidence of tumor metastasis
Description

ID.7

Type de données

boolean

patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
Description

ID.8

Type de données

boolean

patients with hcc who are voluntarily unwilling to be included in the trial
Description

ID.9

Type de données

boolean

Similar models

Eligibility Hepatocellular Carcinoma NCT01392131

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
boolean
ID.2
Item
patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.3
Item
patients with hcc who have evidence of tumor metastasis
boolean
ID.4
Item
patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.5
Item
patients with hcc in whom all possible treatment options have been exhausted.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.7
Item
patients with hcc who have no evidence of tumor metastasis
boolean
ID.8
Item
patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.9
Item
patients with hcc who are voluntarily unwilling to be included in the trial
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial